Supernus Pharmaceuticals | Bienes



Assets Cambio Fecha
Abbott USD 81.45B 34M 2025-03
ANI Pharmaceuticals USD 1.29B 8.73M 2025-03
Aurora Cannabis CAD 866.52M 57.75M 2024-12
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Canopy Growth CAD 1.16B 68.13M 2024-12
Corcept Therapeutics USD 846.46M 5.9M 2025-03
Eisai JPY 1.39T 46.32B 2025-03
Eli Lilly USD 89.39B 10.67B 2025-03
Indivior 1.38B 56M 2025-03
Novo Nordisk 489.16B 91.72B 2025-03
Pacira USD 1.59B 33.15M 2025-03
Perrigo USD 9.76B 112.1M 2025-03
Pfizer USD 208.03B 5.37B 2025-03
Supernus Pharmaceuticals USD 1.37B 25.37M 2024-12
United Therapeutics USD 7.74B 379.9M 2025-03
Xeris Pharmaceuticals USD 323.06M 1.96M 2024-12



Supernus Pharmaceuticals Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.